Description: The video features Chris Onken, a principal and consulting actuary at Milliman. It focuses on identifying equity volatility risk and fundamental strategies to manage it. The discussion covers various types of volatility, including realized, implied, constant, and stochastic volatility, and their applications in projecting asset price volatility. Additionally, the video explores static and dynamic hedging techniques for managing volatility risk. This video provides valuable insights for professionals in the insurance industry.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: Model Risk Management at insurers has been an established practice for well over ten years now. Until recently, a primary focus of model governance was on actuarial models. The Gen AI evolution we’ve experienced in the last two years, has shone a spotlight on “all things AI”. Along with the increased capabilities AI brings, there is increased concern for the proper use of these models, protection of IP, safeguarding of PII, and overall security. This session will bring together a diverse panel to discuss how we can adapt our established practices for these new models to minimize the risks that come with Gen AI and help our organizations optimize the benefits of AI.

Description: This interactive session will compare industry predictions versus what happened with the unwinding of continuous coverage requirements in Medicaid that were first put in place due to the COVID-19 public health emergency. The audience will be able to participate in a guessing game as the panelists review how enrollment could be stabilizing.

Description: This session will focus on what is new and coming at the Appointed Actuary (e.g., Actuarial Guideline ((AG)) 53, equity testing, etc.). We will provide highlights from the updated AAT Practice Note. A particular focus will be paid to asset classes that have received regulatory attention recently ((e.g., commercial mortgage loans, collatoralized loan oblications (CLOs), etc.)).

Description: Insurers have long relied on scenario analysis to understand the long-term impacts of potential business decisions, but the advent of rapidly changing market environments and a growing desire to optimize capital has spurred business leaders to leverage new tools in order to explore potential options.

Description: IUL continues to be the strongest selling UL product. Companies have great profit/pricing expectations, but are those results being achieved? Learn about potential areas of underperformance for IUL including behavior related issues, hedging inefficiency, and mortality issues. The session will also discuss ways to monitor these risks and discuss different means to address potential issues of underperformance in hedging, pricing and in force earnings.

Description: The expanded use of predictive models, algorithms, and external consumer data has drawn the attention of the life insurance industry to the matter of fairness and bias in underwriting, including proposed regulation in states like Colorado and New York and a draft NAIC Model Bulletin. Insurers will benefit taking a proactive approach to verifying that their practices, both current and future, do not result in unfair discrimination. This session will help attendees in understanding potential requirements and reporting insurers must address, techniques and tools for evaluating bias, and challenges in doing so. At the conclusion of the session, attendees will be able to: - Understand proposed regulation and practices regarding fairness and bias - Identify tools and techniques for evaluating bias in their processes - Discuss the challenges the industry will face in addressing fairness in underwriting

Description: In this session, we will provide examples and highlight real-world analytics that have been done to compare providers of tertiary and quaternary (T/Q) services (i.e., complex and potentially rare conditions). We also will address the need for analytics like this, who the potential audiences are, the data necessary to complete an analysis, and we will walk through actual case studies.

Description: Session 3A: State-Specific Enrollment Modeling - Understanding Disenrollment Trends and Population Dynamics